Sandimmun Neoral 100mg by Novartis Pharma is a clinically proven immunosuppressant containing Cyclosporin, designed to prevent organ rejection and treat certain autoimmune conditions. Its microemulsion formulation ensures better absorption and consistent therapeutic effect.
✔️ Prevents organ rejection in kidney, liver, and heart transplants
✔️ Manages autoimmune diseases such as psoriasis, rheumatoid arthritis, and nephrotic syndrome
✔️ Microemulsion technology for enhanced and consistent absorption
✔️ Trusted global brand – Novartis
✔️ Doctor-prescribed in both transplant and autoimmune therapy
Cyclosporin works by selectively suppressing the immune system, helping to prevent it from attacking transplanted organs or the body’s own tissues in autoimmune conditions. It targets T-lymphocytes, which play a central role in immune response.
🔬 High bioavailability for accurate dosing
📦 Reliable supply from a global pharmaceutical leader
👨⚕️ Widely prescribed in transplant and autoimmune care
💊 Consistent plasma levels reduce dosing variability
⚠️ Strict adherence to dosage and timing is critical for effectiveness and safety.
Q1: What is Sandimmun Neoral used for?
A: It's used to prevent organ transplant rejection and treat autoimmune disorders like psoriasis, rheumatoid arthritis, and nephrotic syndrome.
Q2: How is it different from regular Cyclosporin?
A: Neoral is a microemulsion formulation, offering better absorption and less variability in drug levels.
Q3: Can I take Sandimmun Neoral with food?
A: Yes, but it should be taken consistently with or without food for best results.
Q4: What are the side effects?
A: Common side effects include tremors, high blood pressure, increased hair growth, and kidney issues. Always report unusual symptoms to your doctor.
Q5: Is this a lifelong medication?
A: In transplant patients, it may be lifelong. In autoimmune diseases, duration depends on the condition and response to therapy.
🔐 100% Authentic Product
📦 Shipped in secure packaging
🚚 Fast Nationwide Delivery
🩺 Pharmacist support available for guidance